Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

201.23
-0.7700-0.38%
Volume:872.72K
Turnover:177.10M
Market Cap:10.25B
PE:31.88
High:204.16
Open:202.49
Low:200.98
Close:202.00
52wk High:217.12
52wk Low:138.79
Shares:50.95M
Float Shares:50.95M
Volume Ratio:0.55
T/O Rate:1.71%
Dividend:0.40
Dividend Rate:0.20%
EPS(TTM):6.31
EPS(LYR):35.34
ROE:24.54%
ROA:0.10%
PB:1.26
PE(LYR):5.69

Loading ...

Sector Update: Healthcare

MT Newswires Live
·
2 hours ago

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention

THOMSON REUTERS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)

TIPRANKS
·
Yesterday

The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.

Dow Jones
·
Yesterday

Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug

Reuters
·
Yesterday

Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers

Reuters
·
Yesterday

Actinogen Medical Options Expire, Streamlining ASX-Listed Capital Structure

TIPRANKS
·
Yesterday

Cambium Bio Plans New Share Placement to Bolster Capital Base

TIPRANKS
·
Yesterday

Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar

Reuters
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU
·
Yesterday

Gilead Sciences Expands Lenacapavir Access to 14 Countries

MT Newswires Live
·
Sep 15

Gilead announces agreement with PAHO for lenacapavir access

TIPRANKS
·
Sep 15

Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir

THOMSON REUTERS
·
Sep 15

Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds

THOMSON REUTERS
·
Sep 15

Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean

THOMSON REUTERS
·
Sep 15

Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean

Reuters
·
Sep 15

Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access

THOMSON REUTERS
·
Sep 15

Gilead Exec Says Weekly Oral Hiv Prevention Drug Expected to Launch in First Quarter of 2027 - Conf Call

THOMSON REUTERS
·
Sep 15